USPTO serial 79289171
SYNBRICK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GLASSER, CARYN
- Law office
- TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with SYNBRICK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry; biological preparations for use in industry and science; biological preparations for use in manufacture; biological preparations for use in science; biological preparation for use in cell cultures other than for medical or veterinary use; blood culture media for scientific use; biochemicals, namely, precursors for in vitro genetic engineering use; chemical preparations for use in DNA analysis [other than medical]; enzymes for use as biochemical catalysts; biochemicals, namely, polypeptides for in vitro research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific use; diagnostic test kits for scientific use, comprised of reagents, processing chemicals; biochemicals for use in industry and science; molecular biological products for use in industry and science; plasmids for use in industry and science; chromosomes for use in industry and science; diagnostic test kits for use in science, comprised of patch preparations | ACTIVE | — |
| 005 | Preparations for detecting genetic predispositions for medical purposes; biological implants; biological tissue for implantation; biological adjuvants for medical purposes; biological reagents for medical use; biological preparations for the treatment of cancer; mixed biological preparations for medical purposes; biological tissue cultures for medical purposes; bone growth media consisting of biological materials for medical purposes; human plasma protein; blood plasma; blood components; blood substitutes; blood protein fractions; DNA synthesis inhibitors; chemical preparations for use in DNA analysis [medical]; cells for medical use; diagnostic medical reagents for medical use in diagnosing inflammatory, infections, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer; diagnostic test kits for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological endocrine, autoimmune and genetic diseases and cancer, comprised of reagents, processing chemicals and patches; medical diagnostic test kits for detecting pathogens in the environment | ACTIVE | — |
| 009 | DNA microarrays; DNA chips; biochip sensors; bioreactor for cell culturing; laboratory equipment, namely, laboratory apparatus and laboratory instruments; apparatus for sieve tests, the detection of analytes in samples and the identification of the sample type, together with measurement pattern and kits for building and screening of molecular systems as well as parts for it | ACTIVE | — |
| 042 | Genetic research; genetic fingerprinting for scientific or medical research purposes; scientific research relating to genetics; scientific research in the field of genetics and genetic engineering; biological laboratory services; biological cloning services; biological research, clinical research and medical research; services of a chemical and/or biological laboratory; blood analysis services; genetic engineering services; DNA screening for scientific research purposes; research and development in the field of microorganisms and cells; scientific services relating to the isolation and cultivation of human tissues and cells; research and development services for third parties in the fields of diagnostic chemicals, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes, environmental testing processes and industrial quality control processes; chemical sieve analysis; scientific and technological services as well as research and design services relating thereto; industrial analysis; industrial research; services of an industrial designer; quality control; authentication services; design and development of computer hardware and software; research in the area of textile dyes; research in the area of textile dyes consisting of bacteria | ACTIVE | — |
| 044 | Medical and health services relating to naked DNA, genetics and genetic testing; genetic counselling; blood bank services; DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; medical diagnostic services [execution of tests and analysis]; execution of medical tests | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 26, 2022 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 4, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 4, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 1, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 15, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 15, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 4, 2021 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 4, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 5, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 20, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 20, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 15, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |